Effect of Febuxostat on vascular function in patients with hyperuricemia
Not Applicable
- Conditions
- hyperuricemia
- Registration Number
- JPRN-UMIN000009468
- Lead Sponsor
- agasaki University Graduate School of Biomedical Sciences Department of Cardiovascular Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who meet the following criteria are excluded; 1)Patients will not take Febuxostat or Benzbromarone more than three months. 2)Frequent changes of concomitant medications are expected. 3)Patients with severe renal failure(eGFR<30 mL/min/1.73m2) and/ or on dialysis. 4)Pregnant woman 5)Patients have problems of severe allergic diseases on clinical course, or have a history of serious side effects and/or hypersensitivity to these drugs. 6)The physician judges that patients are inappropriate to attend this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of RHI measured by EndoPAT
- Secondary Outcome Measures
Name Time Method